For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.
Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases
Gene Editing Reveals Potential Cancer Treatment Target
Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…
Spellman Social on LinkedIn: Gene editing technology for treatment-resistant cancer could be a…
LabOmics on LinkedIn: Gene editing technology for treatment-resistant cancer could be a…
Buildings November 2021 - Browse Articles
Spencer Waspi on LinkedIn: Life Sciences Deals: By the Numbers
Cancers, Free Full-Text
Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases, Health
Good Day BIO: FDA cut back on Accelerated Approvals in 2022
Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases
In First, Scientists Use CRISPR for Personalized Cancer Treatment
Scientists develop a rapid gene-editing screen to find effects of cancer mutations, MIT News